Solid organ transplant (SOT) recipients are commonly prescribed immunosuppressive therapies which may predispose patients to higher infection and complication rates following total shoulder arthroplasty. This article aims to analyze the effects SOT and subsequent immunosuppressive regimens have on the functional and patient-reported outcomes of total shoulder arthroplasties. A single institution, multisurgeon retrospective case-control study investigating the functional and patient-reported outcomes of shoulder arthroplasty after SOT was conducted between the years of 2010 and 2020. To be included in the study, patients must have undergone SOT prior to primary total shoulder arthroplasty. A 4:1 match-paired control group lacking SOT prior to arthroplasty was then constructed. Thirty-four SOT patients (18 males and 16 females) and 136 control patients (77 male and 59 female) were included in the study. Patients were analyzed who underwent SOT prior to shoulder arthroplasty, with outcomes compared to controls that only underwent arthroplasty. The primary outcomes include range of motion and strength in forward elevation, external rotation, and internal rotation, and patient reported outcomes. There was no significant difference in improvement for range of motion and strength between the 2 cohorts, but within each cohort, improvement was statistically significant. In the SOT patients, forward elevation improved by 56° ± 52°, external rotation increased by 13° ± 20°, and internal rotation increased by 2 vertebral levels. In the non-SOT patients, forward elevation improved by 45° ± 51°, external rotation increased by 16° ± 25°, and internal rotation increased by 3 vertebral levels. SOT patients had equivocal visual analog scale pain and Simple Shoulder Test scores but lower American Shoulder and Elbow Surgeons (59 ± 13 vs. 79 ± 2; P = .002) and SANE (61 ± 30 vs. 84 ± 17; P < .001) scores than non-SOT patients. Complication rates were not significantly higher in the SOT group (15% vs. 6%; P = .05), but incidence of surgical revisions was not significantly different (SOT = 3%; non-SOT = 5%; P = .59). Shoulder arthroplasty is a safe, effective surgical intervention for improving shoulder function in patients with a history of SOT. Despite being on chronic immunosuppressive regimens, our solid organ transplants had comparable clinical outcomes and revision rates, but higher complication rates.
Intramedullary nail fixation is the “gold standard” for surgical intervention of femoral fractures. While many aspects of nail design and patient anatomy have received specific focus, anatomic variations in proximal femoral geometry and greater trochanteric height variation have been poorly studied. Understanding the potential relationship of the greater trochanter to patient demographics may provide an opportunity to improve implant placement. Retrospective review of x‐ray and computed tomography images of the proximal femur was performed. Inclusion criteria consisted of skeletally mature patients over 18 years old with imaging of the proximal femur. Inclusion criteria identified 296 patients. Mean age of included patients was 34 ± 20 years. Average greater trochanter height was 40 ± 8.1 mm. Mean caput‐collum‐diaphyseal angle was 141 ± 8.6 degrees. After identifying significant factors using univariate analyses a multivariable linear regression demonstrated that patient height and caput‐collum‐diaphyseal angle were statistically significant predictors for greater trochanter height. For every 1 cm increase in patient height there was a predicted 0.11 mm increase in greater trochanter height ( p = 0.01). Conversely, every 1 degree increase in caput‐collum‐diaphyseal angle results in an associated 0.17 mm decrease in greater trochanter height ( p < 0.001). This study provides information that may allow for the potential optimization of implant design or implant position to minimize proximal nail protrusion, enhance nail fit and ensure cephalomedullary lag screw position in the head based on the proximal nail dimensions of the implant used.